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Research Article
Neural correlates of hyperalgesia in
the monosodium iodoacetate model
of osteoarthritis pain
Maryam Abaei, PhD, BSc1, Devi R Sagar, PhD, BSc2,3, Elizabeth
G Stockley, BSc2,3, Clare H Spicer3, Malcolm Prior, PhD, BSc4,
Victoria Chapman, PhD, BSc2,3 and Dorothee PAuer, PhD, MD1,2,4
Abstract
Background: The mechanisms driving osteoarthritic pain remain poorly understood, but there is increasing evidence for a
role of the central nervous system in the chronification of pain. We used functional magnetic resonance imaging to investigate
the influence of a model of unilateral knee osteoarthritis on nociceptive processing.
Results: Four to five weeks post intra-articular injection of monosodium iodoacetate (MIA, 1mg) into the left knee, Sprague
Dawley rats were anesthetized for functional magnetic resonance imaging studies to characterize the neural response to a
noxious stimulus (intra-articular capsaicin injection). In a two-arm cross-over design, 5 mM/50 ml capsaicin was injected into
either the left knee (n¼ 8, CAPS-MIA) or right control knee (n¼ 8, CAPS-CON), preceded by contralateral vehicle (SAL)
injection. To assess neural correlates of mechanical hyperalgesia, hindpaws were stimulated with von Frey hairs (8 g: MIA;
15 g: control knee, based on behavioral withdrawal responses). The CAPS-MIA group exhibited significant activation of the
periaqueductal gray, unilateral thalamus and bilateral mensencephalon, superior-colliculus, and hippocampus, with no signifi-
cant activation in the other groups/conditions. Capsaicin injection increased functional connectivity in the mid-brain network
and mediodorsal thalamic nucleus, hippocampus, and globus pallidus, which was significantly stronger in CAPS-MIA compared
to CAPS-CON groups. Mechanical stimulation of the hyperalgesic (ipsilateral to MIA knee) and normalgesic (contralateral)
hindpaws evoked qualitatively different brain activation with more widespread brainstem and anterior cingulate (ACC)
activation when stimulating the hyperalgesic paw, and clearer frontal sensory activation from the normalgesic paw.
Conclusions: We provide evidence for modulation of nociceptive processing in a chronic knee osteoarthritis pain model
with stronger brain activation and alteration of brain networks induced by the pro-nociceptive stimulus. We also report a
shift to a medial pain activation pattern following stimulation of the hyperalgesic hindpaw. Taken together, our data support
altered neural pain processing as a result of peripheral and central pain sensitization in this model.
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Background
The treatment of chronic pain, estimated to aﬀect 19%
of the adult European population,1 remains a clinical
challenge. Osteoarthritis (OA) and arthritis combined
are by far the most common cause of chronic pain in
42%;1 with a clear need for novel treatment strategies.
In order to meet the therapeutic challenge of chronic
arthritis/OA pain, a better understanding of the mech-
anisms of pain chroniﬁcation is required. Animal models
can provide vital insights into the neural mechanisms
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underpinning the experience of chronic pain, and in par-
ticular, the relative contribution of peripheral versus cen-
tral sensitization. Indeed, the evaluation of pain behavior
in rodent models of knee joint OA and their usefulness
for the investigation of potential novel analgesic treat-
ments for OA pain has been established in recent years.2
It is widely recognized that successful development of
eﬀective drug treatments for chronic pain depends on
an interdisciplinary forward and backward translational
approach based on advances in pain neurobiology and
innovative pain models.3,4
Functional neuroimaging studies in OA patients with
chronic pain provided important advances in character-
izing the neural activation sites associated with spontan-
eous OA pain5,6 and those associated with evoked distal
allodynia.5,6 Recent functional brain network analysis at
rest, or during nociception, revealed that chronic OA
pain is associated with functional reorganization,7,8
which is sensitive to treatment eﬀects9 and has predictive
power for placebo analgesia.10 The back-translation of
these imaging ﬁndings to rodent models of OA pain has
thus far only been explored in one model of OA pain, in
which increased baseline functional connectivity in the
nucleus accumbens and the ventroposterior lateral thal-
amus was shown in a surgical model of OA pain.11 Such
studies provide the rationale for the further evaluation of
the impact of altered sensory inputs from the knee joint
on supraspinal networks in these rodent models of
OA pain.
Assessing the functional brain connectome is a highly
topical approach to gain an understanding of complex
brain function and disorders in relation to underlying
dynamic functional processes.12 Inference from func-
tional connectivity studies, however, strongly depends
on a well-controlled experimental design. This limitation
is recognized in human studies but conceivably ever
more pertinent in animal studies when investigating the
poorly deﬁned resting state or ‘‘baseline,’’ not least as the
baseline is confounded by the need for anesthesia to
ensure that subjects are still and welfare is maintained
during imaging. To overcome this, and harness the
advantages of functional connectome studies, this experi-
mental approach needs to be combined with a well
understood, and robust, pain stimulation during ima-
ging. Evaluation of potential network changes in the
supraspinal processing of sensory inputs from the knee
joint which arise clinically can only be achieved by appli-
cation of an additional stimulus during the imaging
protocol in the established models of OA pain.
Recent work from our group has demonstrated
increased activity in the sensory aﬀerent ﬁbers innervat-
ing the knee joint in the monosodium iodoacetate (MIA)
model of OA pain, increased knee joint expression of
transient receptor potential vanilloid 1 (TRPV1) in
human OA knee samples, and that local knee joint
blockade of TRPV1 with a selective antagonist attenu-
ates OA pain behavior in the rodent model.12 These clin-
ical and preclinical data support the notion that TRPV1
makes an important contribution to altered sensory
aﬀerent input from the OA knee joint and thus provide
a rationale for the use of a TRPV1 ligand as an experi-
mental tool to drive knee joint activation in this imaging
study using a model of OA pain. Previously we have
shown that intradermal injection of the TRPV1 ligand
capsaicin (CAPS) increases blood oxygenation level
dependent (BOLD) signal in brain regions associated
with nociceptive processing, including thalamic, peria-
queductal gray (PAG), mesencephalic nuclei, and the
superior colliculus in anesthetized rats.13
The aim of the present study was to investigate the
inﬂuence of established OA of the rat knee joint on the
cerebral hemodynamic responses (using fMRI) to mod-
erate noxious stimulation of the knee joint, and to mild
noxious stimulation of the hindpaw. In the present study
following characterization of pain behavior (weight bear-
ing asymmetry and distal hindpaw mechanical with-
drawal thresholds), rats were anesthetized and eﬀects
of intra-articular injection of the TRPV1 ligand CAPS,
or saline, into the control or OA knee on regional brain
activation were compared using the echoplanar BOLD-
fMRI technique at 7T, thus allowing the characteriza-
tion of both brain activation and connectivity changes
induced by TRVP1 activation. In addition, we used
fMRI to investigate supraspinal central sensitization
using mechanical stimulation of the ipsilateral and
contralateral hindpaws, which, in analogy to human
fMRI studies, was calibrated between OA and saline-
injected knee to induce threshold withdrawal response.
Methods
Model of OA and pain behavior
Animal care was in accordance with the UK Animals
(Scientiﬁc Procedures) Act of 1986. A total of 16
Sprague–Dawley rats (160–200 g at time of MIA injec-
tion; Charles River Laboratories, UK) were maintained
on a 12:12 h light/dark schedule with food and water
available ad libitum. An established model of OA pain
was induced in 16 rats on Day 0 under isoﬂurane anes-
thesia (3%, 1Lmin1 O2). A single intra-articular injec-
tion of MIA (1mg/50l; Sigma, UK) in saline was
administered through the infra-patellar ligament of the
left knee in all rats.14 The MIA model of OA pain has
been widely used, and although it does not mimic the
etiology of OA, it does mimic key clinical features of
OA.15 Pain behavior was assessed for 22 days post injec-
tion after which rats were transferred to undergo ima-
ging studies. Two separate measures of pain behavior
were assessed: change in hindlimb weight distribution
2 Molecular Pain 0(0)
(weight bearing asymmetry), which is a behavioral cor-
relate of hyperalgesia; and hindpaw mechanical with-
drawal thresholds, which provides an index of central
sensitization. Weight distribution was assessed using an
incapacitance tester (Linton Instrumentation, UK) and
was calculated as (weight on contralateral hind limb 
weight on ipsilateral hind limb)/total weight on hind
limbs 100%. Paw withdrawal thresholds (PWTs) were
assessed using a series of von Frey monoﬁlaments
(Semmes–Weinstein monoﬁlaments of bending forces
1–15 g) applied in ascending order of bending force to
the plantar surface as previously described.2 The PWT
was the lowest weight of monoﬁlament that elicited a
withdrawal reﬂex. For analysis, a PWT of greater than
15 g was recorded as 26 g (the next consecutive von Frey
weight in the series). Paw withdrawal data are non-para-
metric; therefore, non-parametric analysis was selected.
Weight bearing data were analyzed using a D’Agostino
and Pearson omnibus normality test (alpha¼ 0.05); data
were not found to be normally distributed; therefore,
non-parametric analysis were also selected. Data were
compared to baseline values and analyzed using a
Kruskall Wallis test with a Dunn’s multiple comparison
post-hoc test.
MRI protocol
fMRI acquisition was performed over four days, 28–32
days post MIA-injection, during which time pain
behavior is stable.2 Rats were anesthetized with isoﬂur-
ane (induction at 4%, maintenance at 2–2.5%), and
temperature, breathing rate, and pulse oximetry was
maintained in physiological range. An intra-articular
cannula was inserted into each knee through the infra-
patellar ligament using a 25G needle and secured
in place.
Scanning was performed on a 7T Bruker MRI magnet
using a volume transmit coil in conjunction with a
receive-only head coil. Anatomical MRI data for the
alignment of fMRI scanning were collected using a T2-
weighted Rapid imaging with refocused echoes sequence
in three orthogonal planes (30 slices, echo time
(TE)¼ 23.6ms, repetition time (TR)¼ 5000ms, spatial
resolution¼ 0.125 0.125 1.00mm3). BOLD-fMRI
data were acquired using a gradient-echo echo planar
imaging sequence with TE¼ 23 ms, TR¼ 2000ms,
Matrix size¼ 64 64 17, spatial resolution¼ 0.46
 0.46 1mm3.
Stimulation paradigm during fMRI acquisition
After anatomical images had been acquired and rats
were physiologically stable, all rats underwent 10min
of mechanical stimulation in a 20 s on and 20 s oﬀ
paradigm to either the ipsilateral or contralateral
hindpaw (eight each, data from one control knee were
discarded for technical reasons) using von Frey hairs
selected on the basis of the behaviorally determined
mechanical withdrawal threshold (average per group)
prior to imaging. The group averaged mechanical with-
drawal threshold of the MIA (left) hind paw was 8 g von
Frey hair vs. 15 g von Frey hair for the control (right)
hind paw.
For the noxious stimulus (CAPS) fMRI scan, a
total of 60min scanning was performed (Figure 1):
10 min baseline (baseline resting state); 15min scan
following intra-articular injection of 50l of vehicle
into either left or right knee (vehicle control state);
35min scan following intra-articular injection of 50l
of 5M CAPS into the opposite knee (CAPS-induced
pain state). Half of the OA rats received the injection
of vehicle to the control (right) knee and CAPS to the
MIA (left) knee (MIA-CAPS), the other half received
vehicle to the MIA knee and CAPS to the control
knee (‘‘CON-CAPS’’). This design was selected to min-
imize possible carry over eﬀects between the von Frey
stimulus and the CAPS condition. In addition, we
balanced the side of von Frey hind paw stimulation
between the groups, half of MIA-CAPS group had
previously undergone ipsilateral or contralateral von
Frey stimulation, to further mitigate against an order
eﬀect.
fMRI analysis
For easier interpretation of results, activation maps
were generated from ﬂipped data. Before any pre-pro-
cessing, data from rats receiving CAPS in their right
knee (CON-CAPS) were rotated around the y axis to
swap the left and right hemispheres; hence, ﬁgures can
be interpreted as though all rats received CAPS into the
left knee. In addition, to study possible laterality
eﬀects of pain processing as suggested in a recent
human pain fMRI meta-analysis,16 we also analyzed
un-ﬂipped data.
For pain threshold (von Frey) activation maps,
model-based fMRI data processing was carried
out using FEAT (fMRI Expert Analysis Tool, Version
5.98; University of Oxford, Oxford, UK), which is
part of FSL (FMRIB Software Library; www.fmrib.ox.
ac.uk/fsl). Speciﬁcally, data were corrected for head
motion using motion correction FMRIB’s linear image
registration tool, removal of the skull and brain extrac-
tion, spatial smoothing at standard 1mm and 3mm to
account for expected low activation height in pain
threshold studies of anesthetized rodents. There were
no diﬀerences in head motion parameters in absolute
(relative to the reference volume) (MIA-CAPS
[0.24 0.01mm] vs. CON-CAPS [0.20 0.08mm, t-test
p¼ 0.42]) or relative displacement (relative to next
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volume) (MIA-CAPS [0.07 0.01mm] vs. CON-CAPS
[0.07 0.01mm, t-test p¼ 0.7]) between the study
groups. Maximum absolute (0.37mm) and relative
(0.11mm) head motion were below the voxel size in all
subjects.
Following pre-processing, time-series statistical ana-
lyses using FMRIB’s improved linear model with local
autocorrelation corrections and block design were used
for ﬁrst-level analyses; to create statistical parametric
maps of the functional data, six motion parameters
were used as variables of no interest. Following the
ﬁrst-level analysis, group analysis was performed using
FMRIB’s Local Analysis of Mixed Eﬀects (statistical
model of mixed-eﬀects variance) to estimate random
eﬀects and variances between subjects. t-tests were per-
formed to determine the diﬀerences in activation within
and between groups (Z> 2.3 and a corrected cluster sig-
niﬁcance threshold of p4 0.05).
Model-free analysis
To assess the eﬀects of intra-articular injection of CAPS
on functional brain connectivity, and how this may be
modulated by MIA-induced TRPV1 sensitization, we
compared functional brain networks (so-called resting
state networks [RSN]) before and after intra-articular
injection of CAPS and between groups (MIA vs. control
knee injection).
Figure 1. Study design: (a) across 32 day time period; (b) stimulation protocol during fMRI: 10min block design (20 s on/20 s off)
mechanical pain stimulation using 8 (or 15) g von Frey to the left (or right [L/R]) hindpaw and then 60min single cross-over fMRI consisting
of baseline, at 10min, intra-articular (i.a.) injection of 50 ml saline (SAL) to MIA or control knee (CON), and at 25min contralateral intra-
articular injection of CAPS (50ml CAPS).
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Data were pre-processed and analyzed using FSL,
including motion correction using motion correction
FMRIB’s linear image registration tool and removal of
non-brain structures with Brain Extraction Tool.
Gaussian spatial smoothing was applied with a full
width half maximum of 1mm. ICA was carried out
using FSL4.1.4 MELODIC software implementing prob-
abilistic independent component analysis (PICA).17 A
multisession temporal concatenation tool in MELODIC
was used to perform PICA related pre-processing and
data conditioning in the group analysis setting.
Spatial ICA using 35 IC maps was applied to detect
RSNs. A rat atlas template18 was used to identify the
anatomical characteristics of the resulting PICA maps.
RSNs included were thalamus, motor cortex, sensory
cortex, and PAG. ICs were subjected to dual-regression
analysis to determine any spatial diﬀerences for individ-
ual networks between the three conditions (post CAPS
vs. vehicle, post CAPS vs. baseline, and vehicle vs. base-
line) and the higher level between group (CAPS injection
sites) diﬀerence of the contrast for baseline vs. post-
CAPS. Comparison between the two CAPS injection
site groups before any injection served as a further val-
idation contrast as the groups and conditions should
have been identical. A statistical analysis was performed
using FSL randomize nonparametric permutation test-
ing, with 5000 permutations and t-test for between group
diﬀerences and paired t-test for within group diﬀerences
using the threshold free cluster enhancement to deter-
mine signiﬁcance at corrected p4 0.05 level.
Results and discussion
Pain behavior
Intra-articular injection of MIA was associated with sig-
niﬁcant decreases in hindlimb weight bearing and
mechanical hindpawwithdrawal thresholds on the ipsilat-
eral side compared to baseline values (Figure 2). These
changes were present from Day 5 post-MIA injection
andweremaintained throughout thedurationof the study.
CAPS-induced brain activation in the MIA model
Using the stimulation paradigm outlined in Figure 1,
intra-articular injection of 50l of CAPS into the
MIA-treated knee induced signiﬁcant activation in
the following brain areas: PAG, unilateral thalamus
and bilateral mesencephalon, superior colliculus,
and hippocampus (Figure 3), but injection of 50l of
CAPS into the control knee did not induce signiﬁcant
brain activation. However, despite the selective CAPS
eﬀect when injected into the MIA pre-treated knee,
with higher level contrast analysis, there were no signiﬁ-
cant diﬀerences between the two groups at the corrected
level likely reﬂecting a type II error. Injection of saline
into control or MIA knee had no eﬀect on brain activity
(no signiﬁcant condition or group eﬀect).
CAPS and MIA effects on functional brain networks
Model free independent component analysis of the con-
catenated fMRI data across both baseline and post
CAPS conditions for all 16 rats detected 35 independent
components (IC). As expected for the level of anesthesia,
IC maps identiﬁed mainly short range RSN correspond-
ing to morphological structures such as the thalamus,
primary motor cortex, somatosensory cortex, hippocam-
pus, and internal capsule/sensory cortex.
We then compared baseline versus CAPS for each
group showing that injection of CAPS into the
MIA knee induced signiﬁcantly increased functional con-
nectivity of several RSNs, including the thalamus,
primary motor cortex, somatosensory and frontal
Figure 2. Intra-articular injection of MIA significantly increased weight bearing asymmetry and decreased hind paw withdrawal thresholds
on the ipsilateral side compared to baseline. Data are expressed as mean SEM (n¼ 16 rats). Statistical analysis was performed using a
Kruskall Wallis test with a Dunn’s multiple comparison test. *p< 0.05, **p< 0.01, *** p< 0.001 compared to baseline.
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sensory cortices, and hippocampus (red–yellow,
Figure 4); no functional connectivity decreases were
noted. CAPS also induced signiﬁcant functional con-
nectivity increases in the sensory motor cortex, parietal
association cortex, and hippocampus in the CON-
CAPS group (blue, Figure 4), again no signiﬁcant
decreases in functional connectivity were noted. The
pattern of functional connectivity increased in MIA-
CAPS versus CON-CAPS groups was only partially
overlapping.
Between groups analysis using dual regression identi-
ﬁed an exclusive diﬀerential eﬀect of intra-articular injec-
tion of CAPS into the MIA knee versus control knee
on the mid-brain network. Speciﬁcally, we report an
increased functional connectivity between mensencepha-
lon-mediodorsal thalamic nucleus and hippocampus and
globus pallidus in the MIA-CAPS group, compared to
the MIA-CON group (Figure 5(a) and (c)).
As expected, we found no diﬀerence in RSN func-
tional connectivity between the two MIA injection
Figure 3. Group mean fMRI activation (red–yellow, p< 0.05 corrected) for MIA-CAPS (CAPS injection into MIA knee, n¼ 8), overlaid
on average T2-structural image. Blue lines indicate the borders for: (a) PAG, (b) Superior-Colliculus, (c) Mesencephalic region,
(d) Thalamus, (e) Hypothalamus, and (f) Hippocampus.
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groups at baseline. Also, the RSN functional connectiv-
ity after vehicle injection in MIA or control knee did not
signiﬁcantly diﬀer from the baseline condition.
Functional MRI of remote hyperalgesia of the hindpaw
Mechanical stimulation of the hindpaw did not evoke
any detectable brain activation between and within the
groups when a 1mm spatial smoothing was employed.
However, using a 3-mm spatial smoothing revealed a
unilateral activation of the contralateral thalamus,
brainstem, and hippocampus following stimulation of
the control (left) hindpaw with a 15-g von Frey hair.
This stimulus was shown to be the threshold hair to
elicit a withdrawal response in awake rats (Table 1,
Figure 6(a)). In contrast, stimulation of the MIA
(right) hindpaw with a 8-g von Frey hair (withdrawal
threshold in the awake rats) was associated with a wide-
spread and bilateral activation pattern, including add-
itional regions of activation in the brainstem, bilateral
thalami, hippocampi and parietal association cortices,
and medial prefrontal cortex/anterior cingulate
Figure 4. CAPS-induced increased functional connectivity map in MIA-CAPS group (red–yellow) and in CON-CAPS group (blue-light) in
axial view, overlaid on T2-weighted template (p< 0.05 corrected). The blue line indicates the structural borders of (a) Mesencephalic
Region, (b) Cortex Insular, (c) Primary Motor Cortex, (d) Caudate-Putamen, (e, f) Cortex Parietal Association, (g) Cortex Somatosensory,
and (h) Hippocampus Anterior Dorsal.
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(Table 1, Figure 6(b)). However, these apparent diﬀer-
ences in activation extent between the groups were not
conﬁrmed by higher level between group contrast ana-
lysis, when corrected for multiple tests. Voxel-based
higher level contrasts are known to be prone to type II
error.
Neural correlates of pain sensitization in the MIA-OA
model
Our study demonstrates neural correlates of peripheral
and central sensitization in the MIA-induced knee OA
pain model in rats. Intra-articular injection of CAPS
into the MIA-treated knee induced bilateral subcortical
and hippocampal activation, but no eﬀect was seen
using the same injection (stimulus locked) in the con-
trol knee (Table 2). Intra-articular injection of CAPS
into both MIA and control knee increased functional
connectivity in several networks, but we found a sig-
niﬁcantly greater increase in mesencephalic functional
connectivity with injection of CAPS into the MIA
knee. Remote hyperalgesia was tested using behavior-
ally locked mechanical von Frey stimulation of the
hindpaw at the respective withdrawal threshold.
Despite the weight of von Frey stimulation in the
MIA group being half of that required for the control
group, we showed widespread bilateral subcortical and
cortical brain activation following von Frey stimula-
tion in the MIA group compared to unilateral activa-
tion of the sensorimotor network during von Frey
stimulation of the control hindpaw.
One of the aims of our study was to investigate
whether MIA-induced sensitization in the chronic knee
OA pain model was characterized by diﬀerential brain
activation, which may reﬂect the behavioral hyperalgesia
demonstrated herein and previously. We report brain
activation in subcortical and hippocampal brain areas
speciﬁc to injection of CAPS into the MIA joint, pre-
dominantly in the brainstem and contralateral thalamus.
Despite diﬀerent models and imaging methods used, our
data are largely consistent with previous preclinical ima-
ging studies reporting subcortical hyperactivation in
hyperalgesic states: increased thalamic and PAG activa-
tion was detected in a pancreatic inﬂammation model19;
increased hypothalamus and brainstem activation in
post-surgical mechanical hyperalgesia20; increased thal-
amic activation in colonic hypersensitivity21; and
increased PAG activation following hindpaw injection
of CAPS.13 We did not observe signiﬁcant primary
somatosensory cortex activation, which was reported in
Figure 5. Intra-articular injection of CAPS induced an increase of functional connectivity in the mediodorsal thalamic nucleus
(a), Hippocampus (b), and Globus Pallidus (c) in MIA-CAPS group compared to CON-CAPS group; corrected P< 0.05.
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earlier fMRI studies following 25l and 75l injection
of CAPS into the dosal forepaw22 and ankle, respect-
ively.23 Sensory cortical hyperactivation may be a hall-
mark of mechanical allodynia as shown in a spinal cord
injury neuropathic pain model.24 The lack of observation
of CAPS-induced activation of the somatosensory and
anterior cingulate cortices is noteworthy given their
common co-activation in human pain studies, and pre-
vious preclinical CAPS injection studies.22,23 This may be
due to protocol diﬀerences related to the scan acquisi-
tion, dose and site of injection, and importantly anesthe-
sia protocol. The cortical somatosensory representation
of both dorsal forepaw and ankle22,23 can be expected to
be larger than that of the knee joint. There are also dif-
ferences in ﬁeld strength (9.4 vs. 7T) and imaging proto-
col (standard vs. higher temporally resolved echoplanar
scans), but the likely main diﬀerence is the use of alpha-
chloralose anesthesia in the prervious studies vs. isoﬂur-
ane in the present study.
Since our data were collected under anesthesia, brain
activation induced by our noxious stimulus can only be
ascribed to enhanced nociception rather than pain
perception, which is precluded by the experimental con-
ditions. All experiments were undertaken under spontan-
eous isoﬂurane inhalation anesthesia at a maintenance
dose of 2%–2.5% to minimize arousal. Under this anes-
thetic regimen, we observed no BOLD activation upon
intra-articular injection of CAPS into the control knee.
This ﬁnding is likely related to the depth of anesthesia as
we cannot exclude that this dose of isoﬂurane had some
analgesic eﬀect despite the lack of analgesia induced by
subanesthetic doses of isoﬂurane.25 Nevertheless, limbic
activation and the lack of detectable cortical activation
following intra-articular injection of CAPS into the MIA
knee is broadly consistent with multivariate pattern ana-
lysis of brain activity at rest in a neuropathic pain model
as studied in awake rats undergoing micro-positron
emission tomography with [18F]ﬂuorodeoxyglucose.26
In this previous study, several brain regions contributed
to an accurate distinction of the spinal nerve ligation
model with mechanical hypersensitivity from sham rats;
speciﬁcally, secondary somatosensory cortex and other
cortical regions showed decreased brain activity while
mainly subcortical and (para-)limbic regions displayed
increased activity. Several of the brain regions with posi-
tive loading for the discrimination model overlapped
with the evoked brain activity we identiﬁed following
von Frey stimulation of the hyperalgesic hindpaw.
Taken together, our experimental protocol had limited
sensitivity to normalgesia but adequate sensitivity to the
hyperalgesic CAPS and von Frey condition.
Interestingly, we identiﬁed more pronounced alter-
ations in the functional connectivity than amplitude
changes during the pronociceptive state. RSN changes
Figure 6. Activation maps (False discovery rate corrected, p< 0.05) evoked by von Frey pain stimulation of the hindpaw with a threshold
hair: (a) ipsilateral to the control (left) knee (15 g von Frey hair) and (b) ipsilateral to the MIA (right) knee (8 g von Frey hair). Von Frey
weights were chosen as the respective minimum force needed to elicit withdrawal in awake rats.
Table 1. Localization of activation in control knee von Frey
hindpaw stimulation according to Paxinos Atlas.18
Coordinate
Location Zscore X Y Z
Control knee von Frey hindpaw stimulation
Thalamus, dorsolateral 2.94 26.7 40 53.4
Hippocampus, posterior,
ventral part
2.89 45.2 56 57.5
Mesencephalic region 2.81 20.5 56 57.5
MIA knee von Frey hindpaw stimulation
Hypothalamus, lateral 3.37 18.5 24 781
Thalamus, dorsolateral 3.32 22.6 32 37
Hippocampus, subiculum 3.29 37 64 34.9
Pedunculopontine
tegmental nucleus
3.28 18.5 80 74
Cortex, somatosensory 3.26 57.5 48 34.9
Mesencephalic region 3.46 12.3 56 76
Cortex, cingulated 2.91 2.05 16 36.9
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were noted following intra-articular injection of CAPS
into both the MIA and control normalgesic knee.
Despite the presence of anesthesia, group IC analysis
(ICA) identiﬁed most known RSNs including the thal-
amus, hippocampus, parietal cortex, motor somatosen-
sory cortices in line with previous studies in anesthetized
rats.27,28 We also showed that hyperalgesia modulated
the functional connectivity changes following intra-
articular injection of CAPS. CAPS injection into the
MIA knee induced a signiﬁcantly greater functional con-
nectivity increase in the mediodorsal thalamic nucleus,
hippocampus, and globus pallidus, compared to injec-
tion of CAPS into the control knee. These data provide
evidence that peripheral and spinal pain sensitization not
only augment nociceptive drive and increase subcortical
brain activation but also increase the functional brain
connectivity response within subcortical and limbic net-
works. This is generally in line with the increased recog-
nition of the power of RSN analysis to understand
altered brain function.12 In a surgical model of OA
(medial meniscal tear), increased functional connectivity
compared to sham operated rats was reported at base-
line, which was modulated by cyclooxygenase-2 inhib-
ition.11 Similar to our study, functional connectivity
changes were reported in the presence of 2% isoﬂurane.
In contrast to the stimulation-free study design in
Upadhyay,11 we observed diﬀerences in BOLD activa-
tion and functional connectivity following intra-articular
injection of CAPS, which we interpret to represent the
up-regulation of the nociceptive drive and hence more
directly reﬂecting central sensitization. Although we
cannot rule out the occurrence of cortical descending
pain augmentation in this model, these eﬀects would be
expected to be symmetric and hence not detectable in our
within group study design. Thus, the observed within
subject diﬀerences in brain activation patterns likely
reﬂect up-regulation of the stimulus input due to either
peripheral hyperalgesia and/or central sensitization.
Strengths of our experimental design include the well-
controlled within subject design using a robust intra-
articular noxious stimulation in a well-characterized
rodent model of chronic OA pain. This allowed us to
directly compare combined BOLD amplitude and func-
tional connectivity changes during an evoked pronoci-
ceptive state in the normalgesic and hyperalgesic knee.
To address the limitation of stimulus-locked injection of
CAPS, we also deployed a behavioral locked nociceptive
design to characterize brain activity changes reﬂecting
brain plasticity associated with central sensitization.
Using a mechanical stimulus, based on that required to
evoke a withdrawal reﬂex response of the hyperalgesic
versus non-hyperalgesic remote hindpaw in the awake
rat, we provide evidence for the central activation pat-
terns associated with central sensitization alone without
the confounds of using diﬀering levels of nociceptive per-
ipheral input. We report unilateral predominantly sen-
sory network activation following stimulation of the
non-hyperalgesic hindpaw, and widespread bilateral acti-
vation of the sensory and midline emotional networks
following stimulation of the hyperalgesic hindpaw. To
the best of our knowledge, behavioral locked nociception
has not previously been reported in imaging studies using
rodent models of chronic pain. Human fMRI studies of
chronic OA pain also typically compare stimuli or tasks
that induce diﬀerential pain in patients and controls.29
The common inference that diﬀerential brain activation
Table 2. Summary of nociceptive brain activation foci and changes in functional connectivity within and between experimental groups and
conditions. NA: Not Applicable.
Contrasts
Anatomical Structure
Activation (corr. P< 0.05) FC (corr. p< 0.05)
MIA-CAPS>CON-CAPS Not significant Mediodorsal thalamic nucleus, Hippocampus, and
Globus Pallidus
MIA-CAPS>Baseline PAG, Superior-Colliculus, Mesencephalic region,
Thalamus, Hypothalamus Medial,
Hippocampus.
Mesencephalic Region, Cortex Insular, Primary
Motor Cortex, Caudate-Putamen, Thalamus,
Cortex Parietal Association, Cortex
Somatosensory, Hippocampus
CON-CAPS>Baseline Not Significant Primary Motor Cortex, Caudate-Putamen,
Cortex Parietal Association, Cortex
Somatosensory
MIA>CON Von-Frey Not Significant NA
MIA hindpaw: 8 gr Von-Frey PAG, Mesencephalic region, Hippocampus, thal-
amus, and cortex parietal association
NA
CON hinpaw: 15 g Von-Frey Hippocampus posterodorsal/subiculum and
cortex parietal association
NA
CAPS: capsaicin; PAG: periaqueductal gray; CON: control; MIA: monosodium iodoacetate; FC: functional connectivity.
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patterns in such experimental designs represent group
diﬀerences in central sensitization, rather than processing
of diﬀerent levels of pain intensity, remains speculative.
The main limitation of our study is our limited sensitivity
to detect brain activation during normalgesic conditions,
and therefore lack of ability to identify signiﬁcance
between condition BOLD amplitude changes. Despite
distinctly diﬀerent activation BOLD amplitude patterns
between experimental groups, only the functional con-
nectivity changes showed signiﬁcant between condition
diﬀerences.
Conclusion
We report that enhanced TRPV1-mediated nociceptive
signaling in a chronic MIA model of OA pain is asso-
ciated with enhanced mesencephalic functional connect-
ivity and subcortical BOLD activation. Using a
behavioral locked nociceptive stimulus, we provide evi-
dence for a change from unilateral sensory nociception
to widespread bilateral brain activation under conditions
of central sensitization in this model of OA pain.
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